Filtered By:
Procedure: Heart Valve Surgery
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 3059 results found since Jan 2013.
Transcatheter vs Surgical Aortic Valve Replacement in Pure Native Aortic Regurgitation
CONCLUSIONS: In Medicare patients with pure native AR, TAVR with the current commercially available transcatheter valves has comparable short-term outcomes. Although long-term outcomes were inferior to SAVR, the possibility of residual confounding, biasing long-term outcomes, given older and frailer TAVR patients, cannot be excluded.PMID:36967709 | DOI:10.1016/j.athoracsur.2022.09.016
Source: The Annals of Thoracic Surgery - March 27, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Amgad Mentias Marwan Saad Venu Menon Grant W Reed Zoran Popovic Douglas Johnston Leonardo Rodriguez Marc Gillinov Brian Griffin Hani Jneid Sidakpal Panaich Samir Kapadia Lars G Svensson Milind Y Desai Source Type: research
Stroke and Noninfective Native Valvular Disease
AbstractPurpose of ReviewEmbolic stroke of undetermined source is a challenging clinical entity. While less common than atrial fibrillation and endocarditis, many noninfective heart valve lesions have been associated with stroke and may be considered as culprits for cerebral infarcts when other more common causes are excluded. This review discusses the epidemiology, pathophysiology, and management of noninfective valvular diseases that are commonly associated with stroke.Recent FindingsCalcific debris from degenerating aortic and mitral valves may embolize to the cerebral vasculature causing small- or large-vessel ischemia...
Source: Current Cardiology Reports - March 27, 2023 Category: Cardiology Source Type: research
Suitability of TAVI in low-risk patients
Nature Reviews Cardiology, Published online: 21 March 2023; doi:10.1038/s41569-023-00862-6In the Evolut Low Risk study, transcatheter aortic valve implantation in low-risk patients with severe aortic stenosis compared favourably with surgical aortic valve replacement in terms of all-cause mortality or disabling stroke at 3 years.
Source: Nature Reviews Cardiology - March 21, 2023 Category: Cardiology Authors: Gregory B. Lim Source Type: research
Case Series of Early Structural Valve Deterioration of Trifecta Bioprosthesis - New Zealand Experience
CONCLUSION: The Trifecta valve has an acceptable safety profile and offers good hemodynamics due to the externally mounted leaflets. However, our experience of early SVD and failure is concerning for valve durability. Further comparison to other bioprosthetic valves and longer term follow-up are required to characterize the mechanism of failures.PMID:36935120 | DOI:10.5761/atcs.oa.23-00007
Source: Annals of Thoracic and Cardiovascular Surgery - March 19, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Trevor D Tnay Lily Kang Andrew Mekhail Sean D Galvin Source Type: research
Clonal Hematopoiesis and the Heart: a Toxic Relationship
Curr Oncol Rep. 2023 Mar 15. doi: 10.1007/s11912-023-01398-1. Online ahead of print.ABSTRACTPURPOSE OF REVIEW: Clonal hematopoiesis (CH) refers to the expansion of hematopoietic stem cell clones and their cellular progeny due to somatic mutations, mosaic chromosomal alterations (mCAs), or copy number variants which naturally accumulate with age. CH has been linked to increased risk of blood cancers, but CH has also been linked to adverse cardiovascular outcomes.RECENT FINDINGS: A combination of clinical outcome studies and mouse models have offered strong evidence that CH mutations either correlate with or cause atheroscle...
Source: Atherosclerosis - March 15, 2023 Category: Cardiology Authors: Jeffrey L Jensen Saumya Easaw Travis Anderson Yash Varma Jiandong Zhang Brian C Jensen Catherine C Coombs Source Type: research
Encouraging 3-Year Data for TAVR in Low-Risk Patients: EVOLUT Encouraging 3-Year Data for TAVR in Low-Risk Patients: EVOLUT
The 3-year results show that low-surgical-risk patients undergoing aortic valve replacement continue to show lower rates of all-cause mortality and disabling stroke with TAVR compared with surgery.Medscape Medical News
Source: Medscape Cardiology Headlines - March 6, 2023 Category: Cardiology Tags: Cardiology News Source Type: news
New VOYAGER PAD Analysis Confirms Consistent Benefit of XARELTO ® (rivaroxaban) Plus Aspirin Following Lower Extremity Revascularization (LER)
TITUSVILLE, NJ, March 5, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced data from a new prespecified analysis from the Phase 3 VOYAGER PAD clinical trial reinforcing the benefits of the XARELTO® (rivaroxaban) vascular dose (2.5 mg twice daily plus aspirin 100 mg once daily) over standard of care (aspirin alone), demonstrating consistent benefit at 30 days, 90 days and up to three years following LER in patients with PAD. Lower extremity revascularization, also called peripheral revascularization, is a procedure that restores blood flow in blocked arteries or veins. This analysis of ...
Source: Johnson and Johnson - March 5, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Minimally Invasive Mitral Valve Surgery in the Elderly
CONCLUSION: miMVS results in satisfactory early postoperative outcomes in elderly patients.PMID:36858067 | DOI:10.1055/s-0043-1762940
Source: The Thoracic and Cardiovascular Surgeon - March 1, 2023 Category: Cardiovascular & Thoracic Surgery Authors: Maximilian Franz Nunzio Davide De Manna Saskia Schulz Fabio Ius Axel Haverich Serghei Cebotari Igor Tudorache Jawad Salman Source Type: research
